Annual ROE
-142.49%
-34.58%-32.05%
December 31, 2023
Summary
- As of February 7, 2025, CANF annual return on equity is -142.49%, with the most recent change of -34.58% (-32.05%) on December 31, 2023.
- During the last 3 years, CANF annual ROE has risen by +196.71% (+57.99%).
- CANF annual ROE is now -156.97% below its all-time high of -55.45%, reached on December 31, 2015.
Performance
CANF ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-73.38%
+48.50%+39.79%
June 30, 2024
Summary
- As of February 7, 2025, CANF quarterly return on equity is -73.38%, with the most recent change of +48.50% (+39.79%) on June 30, 2024.
- Over the past year, CANF quarterly ROE has increased by +58.06% (+44.17%).
- CANF quarterly ROE is now -22.38% below its all-time high of -59.96%, reached on September 30, 2016.
Performance
CANF Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CANF ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.0% | +44.2% |
| 3 y3 years | +58.0% | +53.5% |
| 5 y5 years | +12.9% | +52.3% |
CANF ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.0% | at low | at high | +52.5% |
| 5 y | 5-year | -32.0% | +69.2% | at high | +72.1% |
| alltime | all time | -157.0% | +69.2% | -22.4% | +93.4% |
Can-Fite BioPharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | -73.38%(-39.8%) |
| Dec 2023 | -142.49%(+32.0%) | -121.88%(-12.0%) |
| Sep 2023 | - | -138.47%(+5.3%) |
| Jun 2023 | - | -131.44%(+8.1%) |
| Mar 2023 | - | -121.59%(+15.2%) |
| Dec 2022 | -107.91%(-12.5%) | -105.53%(-0.6%) |
| Sep 2022 | - | -106.22%(-13.2%) |
| Jun 2022 | - | -122.44%(-13.0%) |
| Mar 2022 | - | -140.80%(-8.9%) |
| Dec 2021 | -123.34%(-63.6%) | -154.51%(-8.3%) |
| Sep 2021 | - | -168.56%(+6.8%) |
| Jun 2021 | - | -157.87%(-9.6%) |
| Mar 2021 | - | -174.67%(-17.1%) |
| Dec 2020 | -339.20%(-26.7%) | -210.73%(-1.0%) |
| Sep 2020 | - | -212.82%(-19.1%) |
| Jun 2020 | - | -263.13%(+4.0%) |
| Mar 2020 | - | -253.11%(-3.0%) |
| Dec 2019 | -462.71%(+182.7%) | - |
| Dec 2019 | - | -260.86%(+30.3%) |
| Sep 2019 | - | -200.22%(+30.0%) |
| Jun 2019 | - | -153.98%(+22.5%) |
| Mar 2019 | - | -125.67%(+8.5%) |
| Dec 2018 | -163.68%(+14.8%) | - |
| Dec 2018 | - | -115.87%(+37.9%) |
| Sep 2018 | - | -84.05%(-23.8%) |
| Jun 2018 | - | -110.31%(-10.2%) |
| Mar 2018 | - | -122.85%(-13.7%) |
| Dec 2017 | -142.64% | - |
| Dec 2017 | - | -142.40%(-15.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | -167.45%(+4.5%) |
| Jun 2017 | - | -160.31%(+24.4%) |
| Mar 2017 | - | -128.87%(+16.7%) |
| Dec 2016 | -115.33%(+108.0%) | - |
| Dec 2016 | - | -110.44%(+84.2%) |
| Sep 2016 | - | -59.96%(-15.1%) |
| Jun 2016 | - | -70.65%(-9.7%) |
| Mar 2016 | - | -78.27%(+16.6%) |
| Dec 2015 | -55.45%(-48.6%) | - |
| Dec 2015 | - | -67.14%(-43.6%) |
| Sep 2015 | - | -118.99%(+31.0%) |
| Jun 2015 | - | -90.83%(+4.1%) |
| Mar 2015 | - | -87.24%(-27.9%) |
| Dec 2014 | -107.85%(-75.8%) | - |
| Dec 2014 | - | -121.00%(-37.1%) |
| Sep 2014 | - | -192.42%(-13.4%) |
| Jun 2014 | - | -222.26%(-11.4%) |
| Mar 2014 | - | -250.78%(-46.1%) |
| Dec 2013 | -444.87%(+2.9%) | -465.67%(-25.3%) |
| Sep 2013 | - | -623.14%(+3.9%) |
| Jun 2013 | - | -599.53%(+17.6%) |
| Mar 2013 | - | -509.64%(+39.3%) |
| Dec 2012 | -432.31%(+75.1%) | - |
| Dec 2012 | - | -365.74%(-54.0%) |
| Sep 2012 | - | -795.60%(+34.0%) |
| Jun 2012 | - | -593.71%(-4.2%) |
| Mar 2012 | - | -619.67%(-22.1%) |
| Dec 2011 | -246.85% | - |
| Dec 2011 | - | -795.10%(-28.4%) |
| Sep 2011 | - | -1109.80% |
FAQ
- What is Can-Fite BioPharma annual return on equity?
- What is the all time high annual ROE for Can-Fite BioPharma?
- What is Can-Fite BioPharma annual ROE year-on-year change?
- What is Can-Fite BioPharma quarterly return on equity?
- What is the all time high quarterly ROE for Can-Fite BioPharma?
- What is Can-Fite BioPharma quarterly ROE year-on-year change?
What is Can-Fite BioPharma annual return on equity?
The current annual ROE of CANF is -142.49%
What is the all time high annual ROE for Can-Fite BioPharma?
Can-Fite BioPharma all-time high annual return on equity is -55.45%
What is Can-Fite BioPharma annual ROE year-on-year change?
Over the past year, CANF annual return on equity has changed by -34.58% (-32.05%)
What is Can-Fite BioPharma quarterly return on equity?
The current quarterly ROE of CANF is -73.38%
What is the all time high quarterly ROE for Can-Fite BioPharma?
Can-Fite BioPharma all-time high quarterly return on equity is -59.96%
What is Can-Fite BioPharma quarterly ROE year-on-year change?
Over the past year, CANF quarterly return on equity has changed by +58.06% (+44.17%)